MIRACLE - art photonics

Latest News

12 August 2026

art photonics GmbH Welcomes Joachim Gerike as New Product Line Manager

By Stanislav Perevoschikov

We are happy to welcome Joachim Gerike to the art photonics GmbH team as our new Product Line Manager. With a Dipl.-Ing. in Mechanical Engineering from Technische Universität Braunschweig and a career in the optical industry dating back to 1996, Joachim brings decades of highly specialized expertise to our operations. His extensive background covers everything […]

24 July 2026

Discover the Ultimate Fiber Connection for High-Vacuum Optical Setups

By Stanislav Perevoschikov

When your research or production takes you into extreme environments, maintaining perfect optical transmission should never be a hurdle. At art photonics GmbH, we invite you to explore our FlexiRay® Vacuum Fiber Optic Feedthroughs - engineered to provide a highly flexible, continuous optical path directly into your vacuum or pressurized chambers. Whether you are conducting […]

Latest Events

22 August 2026

SPECTARIS 2026 | 16–22 September 2026 | Berlin, Germany

By Stanislav Perevoschikov

art photonics GmbH is pleased to announce our participation in the upcoming SPECTARIS 2026 event series in Berlin this September. Our CEO, Dr. Stefanie Foerster, and our Product Line Manager, Joachim Gerike, will be representing the company during a dynamic week dedicated to industry collaboration, technological growth, and innovation. The schedule begins on September 16 […]

6 August 2026

JASIS 2026 | 2-4 September 2026 | Makuhari Messe, Japan

By Stanislav Perevoschikov

We are pleased to announce that our R&D Manager, Alexander Novikov, will be attending JASIS 2026. If you are planning to attend the event and are looking to optimize your Process Analytical Technology (PAT), this is an excellent opportunity to connect. At art photonics GmbH, we act as the fiber optic bridge between your complex […]

MIRACLE: Mid-infrared arthroscopy innovative imaging system for real-time clinical in depth examination and diagnosis of degenerative joint diseases

MIRACLE will push towards commercialisation the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage enabling early diagnosis of degenerative joint diseases such as osteoarthritis (OA). The proposed device is intended for use during arthroscopy, a minimally invasive surgery. Currently, the surgeon’s decision-making is based on visual inspection and manual probing of the cartilage tissue which is highly subjective and of poor repeatability. MIRACLE concept is to assess changes to the biochemical composition of articular cartilage, which precede OA. This will be achieved combining three novel photonics components: (i) a quantum cascade laser array tailored to biodiagnostics, (ii) an on-chip beam combiner for efficient radiation coupling, and (iii) a MIR sensing probe for imaging. These components will be integrated in a medical device to be placed in the arthroscopy market. In addition, to add value to the European medical equipment industry, MIRACLE strives towards cost reduction of OA patients contributing to more affordable public healthcare and promoting well-being in the European ageing population.

art photonics‘ role in joint work will be to develop and provide flexible IR-fibers for quantum cascade lasers (QCL) coupling with the distal end of arthroscopic probe.

The unique polycrystalline fiber technology for 4-16µm range and unique design of ATR-diamond tip will enable efficient and flexible coupling of QCL with detector. This worldwide first prototype of IR-fiber spectral sensor will open the first opportunity to see molecular changes in cartilage composition in-vivo, to link them with its specific decease and find the best way of the related treatment for a fast cartilage recovery.

This project received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 780598. The project is an initiative of the Photonics Public Private Partnership.